THE USEFULNESS OF MOOD STABILIZERS IN THE TREATMENT OF BIPOLAR DEPRESSION

被引：0
|
作者：
Cruz, N. [1 ]
Nivoli, A. [1 ]
Vieta, E. [1 ]
机构：
[1] Univ Barcelona, Hosp Clin, Bipolar Disorders Dept, IDIBAPS,CIBERSAM, Barcelona, Spain
来源：
EUROPEAN PSYCHIATRY | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
S19-02
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Substance use disorders in bipolar disorders: Clinical correlates and treatment response to mood stabilizers
    Menculini, Giulia
    Steardo, Luca, Jr.
    Verdolini, Norma
    Cirimbilli, Federica
    Moretti, Patrizia
    Tortorella, Alfonso
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 300 : 326 - 333
  • [42] Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study
    Bahk, WM
    Yoon, BH
    Lee, KU
    Chae, JH
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (03) : 181 - 185
  • [43] Structural plasticity and neuronal resilience: are these targets for mood stabilizers and antidepressants in the treatment of bipolar disorder?
    Manji, HK
    Young, LT
    BIPOLAR DISORDERS, 2002, 4 (02) : 77 - 79
  • [44] Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
    Correll, Christoph U.
    Detraux, Johan
    De Lepeleire, Jan
    De Hert, Marc
    WORLD PSYCHIATRY, 2015, 14 (02) : 119 - 136
  • [45] Adjunctive Mood Stabilizers Are Not the Same as a Placebo-Only Arm in Bipolar Depression Trials: Reply to Terao
    Goldberg, Joseph F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (04)
  • [46] Acute and maintenance treatment with mood stabilizers
    Bowden, CL
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (03): : 269 - 275
  • [47] Outcomes of Three Treatment Strategies in Bipolar Disorder Using Conventional Mood Stabilizers and Antipsychotic Drugs
    Tournier, Marie
    Neumann, Anke
    Pambrun, Elodie
    Weill, Alain
    Chaffiol, Jean-Philippe
    Alla, Francois
    Begaud, Bernard
    Maura, Geric
    Verdoux, Helene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 588 - 588
  • [48] Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study
    Chen, Chih-Ken
    Yang, Shu-Yu
    Park, Seon-Cheol
    Jang, Ok-Jin
    Zhu, Xiaomin
    Xiang, Yu-Tao
    Ouyang, Wen-Chen
    Javed, Afzal
    Khan, M. Nasar Sayeed
    Grover, Sandeep
    Avasthi, Ajit
    Kallivayalil, Roy Abraham
    Chee, Kok Yoon
    Chemi, Norliza
    Kato, Takahiro A.
    Hayakawa, Kohei
    Pariwatcharakul, Pornjira
    Maramis, Margarita
    Seneviratne, Lakmi
    Sim, Kang
    Tang, Wai Kwong
    Oo, Tin
    Sartorius, Norman
    Tan, Chay-Hoon
    Chong, Mian-Yoon
    Park, Yong Chon
    Shinfuku, Naotaka
    Lin, Shih-Ku
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 85
  • [49] Lurasidone and Mood Stabilizers in Treatment-Resistant Unipolar Depression: A Case Report Study
    Nunez, Nicolas A.
    Gobbi, Gabriella
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 263 - 264
  • [50] Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression
    Goldberg, JF
    Burdick, KE
    Endick, CJ
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03): : 564 - 566
12345